Catalog Number PROC2 |
Device Problem
Material Erosion (1214)
|
Patient Problems
Erosion (1750); Pain (1994); Surgical procedure (2357)
|
Event Type
Injury
|
Event Description
|
It was reported that the patient underwent a gynecological surgical procedure on (b)(6) 2010 and mesh was implanted.It was reported that the patient experienced pain, erosion of her internal bodily tissue and other injuries following the procedure.It was reported that the patient has undergone multiple surgeries and revisionary procedures.No additional information was provided.
|
|
Manufacturer Narrative
|
(b)(4).Conclusion: no conclusion can be drawn at this time.Should additional information be obtained, a supplemental 3500a form will be submitted accordingly.In addition, a review of the batch manufacturing records was conducted and the batch met all finished goods release criteria.(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).Reporting period april 1, 2015 through may 31, 2015.
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(4) 2015.
|
|
Manufacturer Narrative
|
Date sent to the fda: 04/19/2017.Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2015 through may 31, 2015.
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.Reporting period (b)(4) 2015 through (b)(4) 2015.Supplemental 12 - attachment: [06-30-2015 otp supplemental 12.Xlsx].
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4) reporting period (b)(6) 2015 through (b)(6) 2015 supplemental 14 - attachment: [(b)(6) 2015 otp supplemental 14.Xlsx].
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2015 through may 31, 2015.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4) reporting period (b)(6) 2015 through (b)(6) 2015 supplemental 15 - attachment: [(b)(6) 2015 otp supplemental 15.Xlsx].
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2015 through may 31, 2015.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2015 through may 31, 2015.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period april 1, 2015 through may 31, 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: 08/23/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period april 1, 2015 through may 31, 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: 12/28/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period april 1, 2015 through may 31, 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: 2/12/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period april 1, 2015 through may 31, 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: 04/24/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period april 1, 2015 through may 31, 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: 06/23/2020.Ethicon mdr summary reporting exemption e2013037.Reporting period april 1, 2015 through may 31, 2015.
|
|
Search Alerts/Recalls
|